Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinming Yu

Showing results (281-290 of 822) with videos related to

Pageof 83
Sort By:
Pathology, Research and Practice|July 22, 2014
ERCC1 expression and tumor regression predict survival in esophageal squamous cell carcinoma patients receiving combined trimodality therapyHong Ge, Yufei Lu, Yongshun Chen, et al.
Plos One|April 14, 2016
Accuracy of McMonnies Questionnaire as a Screening Tool for Chinese Ophthalmic OutpatientsFurong Tang, Jiwei Wang, Zheng Tang, et al.
Breast Cancer Research and Treatment|October 2, 2017
Predictors of the quality of life in Chinese breast cancer survivorsJuan Xia, Zheng Tang, Qinglong Deng, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|March 18, 2016
Predicting the prevalence of peripheral arterial diseases: modelling and validation in different cohortsYiqiang Zhan, Jie Zhuang, Ying Dong, et al.
Journal of Hematology & Oncology|August 18, 2018
Abscopal effect of radiotherapy combined with immune checkpoint inhibitorsYang Liu, Yinping Dong, Li Kong, et al.
Cell Communication and Signaling : CCS|May 24, 2023
Radiation combined with immune checkpoint inhibitors for unresectable locally advanced non-small cell lung cancer: synergistic mechanisms, current state, challenges, and orientationsLeilei Wu, Zhenshan Zhang, Menglin Bai, et al.
Medcomm|May 19, 2023
Optimum fractionation of radiation to combine PD-1 blockadeFeifei Teng, Tianwen Yin, Xiao Ju, et al.
Cancer Letters|March 5, 2023
Enhanced E6AP-mediated ubiquitination of ENO1 via LINC00663 contributes to radiosensitivity of breast cancer by regulating mitochondrial homeostasisJianli Ma, Junwen Zhu, Jingtong Li, et al.
Cancer Management and Research|May 23, 2019
Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patientsYi Sun, Wenqiang Li, Ai-Jie Li, et al.
Cancer Letters|July 8, 2021
PET/CT metabolic patterns in systemic immune activation: A new perspective on the assessment of immunotherapy response and efficacyPeng Jin, Jianing Li, Yingtao Meng, et al.
Pageof 83

Showing results (281-290 of 822) with videos related to

Sort By:
Pageof 83
Pathology, Research and Practice|July 22, 2014
ERCC1 expression and tumor regression predict survival in esophageal squamous cell carcinoma patients receiving combined trimodality therapyHong Ge, Yufei Lu, Yongshun Chen, et al.
Plos One|April 14, 2016
Accuracy of McMonnies Questionnaire as a Screening Tool for Chinese Ophthalmic OutpatientsFurong Tang, Jiwei Wang, Zheng Tang, et al.
Breast Cancer Research and Treatment|October 2, 2017
Predictors of the quality of life in Chinese breast cancer survivorsJuan Xia, Zheng Tang, Qinglong Deng, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|March 18, 2016
Predicting the prevalence of peripheral arterial diseases: modelling and validation in different cohortsYiqiang Zhan, Jie Zhuang, Ying Dong, et al.
Journal of Hematology & Oncology|August 18, 2018
Abscopal effect of radiotherapy combined with immune checkpoint inhibitorsYang Liu, Yinping Dong, Li Kong, et al.
Cell Communication and Signaling : CCS|May 24, 2023
Radiation combined with immune checkpoint inhibitors for unresectable locally advanced non-small cell lung cancer: synergistic mechanisms, current state, challenges, and orientationsLeilei Wu, Zhenshan Zhang, Menglin Bai, et al.
Medcomm|May 19, 2023
Optimum fractionation of radiation to combine PD-1 blockadeFeifei Teng, Tianwen Yin, Xiao Ju, et al.
Cancer Letters|March 5, 2023
Enhanced E6AP-mediated ubiquitination of ENO1 via LINC00663 contributes to radiosensitivity of breast cancer by regulating mitochondrial homeostasisJianli Ma, Junwen Zhu, Jingtong Li, et al.
Cancer Management and Research|May 23, 2019
Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patientsYi Sun, Wenqiang Li, Ai-Jie Li, et al.
Cancer Letters|July 8, 2021
PET/CT metabolic patterns in systemic immune activation: A new perspective on the assessment of immunotherapy response and efficacyPeng Jin, Jianing Li, Yingtao Meng, et al.
Pageof 83